Sanarus Technologies
 | |
| ISIN | 🆔 |
|---|---|
| Industry | Medical Devices |
| Founded 📆 | 2008 |
| Founder 👔 | |
| Headquarters 🏙️ | Pleasanton, California, United States |
Area served 🗺️ | United States |
| Members | |
Number of employees | |
| 🌐 Website | Official website |
| 📇 Address | |
| 📞 telephone | |
Sanarus Technologies is a medical device company that develops and markets minimally-invasive, office-based breast care diagnosis and treatment solutions to patients and physicians. The company provides cryoablation technology that is used to freeze tissue for diagnostic and therapeutic breast care procedures.[1]
The company was founded in 2008 and is headquartered in Pleasanton, California.
Products
- Visica 2 uses cryoablation to treat biopsy-proven fibroadenomas and is currently in a Phase 2 clinical trial for the treatment of breast cancer.[2]
Society and culture
In 2008, the Visica 2 Treatment System was named a runner-up in the Medical Device category at the Wall Street Journal's Technology Innovation Awards.[3]
References
External links
This article "Sanarus Technologies" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Sanarus Technologies. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
